Name | Value |
---|---|
Revenues | 1,259.4M |
Cost of Revenue | 580.2M |
Gross Profit | 679.2M |
Operating Expense | 411.0M |
Operating I/L | 254.8M |
Other Income/Expense | -22.8M |
Interest Income | 0.6M |
Pretax | 217.6M |
Income Tax Expense | 40.6M |
Net Income/Loss | 177.0M |
PerkinElmer, Inc. operates in the diagnostics, life sciences, and applied services markets worldwide. The company's Discovery & Analytical Solutions segment offers reagents, informatics, and detection and imaging technologies for life sciences research, contract research, laboratory services, environmental analysis, and industrial applications. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for early detection of genetic disorders and infectious disease testing. Its products are used in genetic testing, screening, and genomic workflows for applications in oncology, immunodiagnostics, and drug discovery, serving pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies.